Literature DB >> 24951129

Plasmodium falciparum infection is associated with Epstein-Barr virus reactivation in pregnant women living in malaria holoendemic area of Western Kenya.

Ibrahim I Daud1, Sidney Ogolla, Asito S Amolo, Eunice Namuyenga, Kenneth Simbiri, Elizabeth A Bukusi, Zipporah W Ng'ang'a, Robert Ploutz-Snyder, Peter O Sumba, Arlene Dent, Rosemary Rochford.   

Abstract

The role of Plasmodium falciparum malaria in Epstein-Barr virus (EBV) transmission among infants early in life remain elusive. We hypothesized that infection with malaria during pregnancy could cause EBV reactivation leading to high EBV load in circulation, which could subsequently enhance early age of EBV infection. Pregnant women in Kisumu, where P. falciparum malaria is holoendemic, were actively followed monthly through antenatal visits (up to 4 per mother) and delivery. Using real-time quantitative (Q)-PCR, we quantified and compared EBV and P. falciparum DNA levels in the blood of pregnant women with and without P. falciparum malaria. Pregnant women that had malaria detected during pregnancy were more likely to have detectable EBV DNA than pregnant women who had no evidence of malaria infection during pregnancy (64 vs. 36 %, p = 0.01). EBV load as analyzed by quantifying area under the longitudinal observation curve (AUC) was significantly higher in pregnant women with P. falciparum malaria than in women without evidence of malaria infection (p = 0.01) regardless of gestational age of pregnancy. Increase in malaria load correlated with increase in EBV load (p < 0.0001). EBV load was higher in third trimester (p = 0.04) than first and second trimester of pregnancy independent of known infections. Significantly higher frequency and elevated EBV loads were found in pregnant women with malaria than in women without evidence of P. falciparum infection during pregnancy. The loss of control of EBV latency following P. falciparum infection during pregnancy and subsequent increase in EBV load in circulation could contribute to enhanced shedding of EBV in maternal saliva and breast milk postpartum, but further studies are needed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24951129      PMCID: PMC4272914          DOI: 10.1007/s10995-014-1546-4

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  49 in total

1.  Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR.

Authors:  C C Hermsen; D S Telgt; E H Linders; L A van de Locht; W M Eling; E J Mensink; R W Sauerwein
Journal:  Mol Biochem Parasitol       Date:  2001-12       Impact factor: 1.759

Review 2.  How immune mechanisms are affected by pregnancy.

Authors:  Patrizia Luppi
Journal:  Vaccine       Date:  2003-07-28       Impact factor: 3.641

Review 3.  Endemic Burkitt's lymphoma: a polymicrobial disease?

Authors:  Rosemary Rochford; Martin J Cannon; Ann M Moormann
Journal:  Nat Rev Microbiol       Date:  2005-02       Impact factor: 60.633

4.  Epstein-Barr virus infection during pregnancy and the risk of adverse pregnancy outcome.

Authors:  Anne Eskild; Anne-Lise Bruu; Babill Stray-Pedersen; Pål Jenum
Journal:  BJOG       Date:  2005-12       Impact factor: 6.531

Review 5.  Gammaherpesviruses and lymphoproliferative disorders.

Authors:  Ethel Cesarman
Journal:  Annu Rev Pathol       Date:  2013-10-09       Impact factor: 23.472

6.  Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children.

Authors:  Ann M Moormann; Kiprotich Chelimo; Odada P Sumba; Mary L Lutzke; Robert Ploutz-Snyder; Duane Newton; James Kazura; Rosemary Rochford
Journal:  J Infect Dis       Date:  2005-03-09       Impact factor: 5.226

7.  Placental malaria is associated with increased risk of nonmalaria infection during the first 18 months of life in a Beninese population.

Authors:  Antoine Rachas; Agnès Le Port; Gilles Cottrell; José Guerra; Isabelle Choudat; Julie Bouscaillou; Achille Massougbodji; André Garcia
Journal:  Clin Infect Dis       Date:  2012-05-18       Impact factor: 9.079

8.  Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses the accessory cell-dependent T cell proliferation.

Authors:  Claudia Cristina Motrán; Fernando López Díaz; Adriana Gruppi; Daniela Slavin; Bruno Chatton; José Luis Bocco
Journal:  J Leukoc Biol       Date:  2002-09       Impact factor: 4.962

Review 9.  The epidemiology and consequences of maternal malaria: a review of immunological basis.

Authors:  Brown J Okoko; G Enwere; M O C Ota
Journal:  Acta Trop       Date:  2003-07       Impact factor: 3.112

Review 10.  The evolution of antigen-specific CD8+ T cell responses after natural primary infection of humans with Epstein-Barr virus.

Authors:  Margaret F C Callan
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

View more
  11 in total

1.  Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.

Authors:  Sidney Ogolla; Ibrahim I Daud; Amolo S Asito; Odada P Sumba; Collins Ouma; John Vulule; Jaap M Middeldorp; Arlene E Dent; Saurabh Mehta; Rosemary Rochford
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

2.  Epstein-Barr Virus Type 2 Infects T Cells in Healthy Kenyan Children.

Authors:  Carrie B Coleman; Ibrahim I Daud; Sidney O Ogolla; Julie A Ritchie; Nicholas A Smith; Peter O Sumba; Arlene E Dent; Rosemary Rochford
Journal:  J Infect Dis       Date:  2017-09-15       Impact factor: 5.226

3.  Breast Milk as a Potential Source of Epstein-Barr Virus Transmission Among Infants Living in a Malaria-Endemic Region of Kenya.

Authors:  Ibrahim I Daud; Carrie B Coleman; Nicholas A Smith; Sidney Ogolla; Kenneth Simbiri; Elizabeth A Bukusi; Zipporah W Ng'ang'a; Peter O Sumba; John Vulule; Robert Ploutz-Snyder; Arlene E Dent; Rosemary Rochford
Journal:  J Infect Dis       Date:  2015-05-17       Impact factor: 5.226

4.  Modeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection.

Authors:  Arnold Reynaldi; Timothy E Schlub; Erwan Piriou; Sidney Ogolla; Odada P Sumba; Ann M Moormann; Rosemary Rochford; Miles P Davenport
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

Review 5.  Malaria - how this parasitic infection aids and abets EBV-associated Burkitt lymphomagenesis.

Authors:  Ann M Moormann; Jeffrey A Bailey
Journal:  Curr Opin Virol       Date:  2016-09-27       Impact factor: 7.090

6.  Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs.

Authors:  Katherine R Sabourin; Sidney Ogolla; Ibrahim I Daud; Conner L Jackson; Wendell Miley; Nazzarena Labo; Denise Whitby; Rosemary Rochford
Journal:  Infect Agent Cancer       Date:  2020-11-26       Impact factor: 2.965

7.  IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.

Authors:  Gabriela Samayoa-Reyes; Conner Jackson; Sidney Ogolla; Katherine Sabourin; Adeola Obajemu; Arlene E Dent; Ludmilla Prokunina-Olsson; Rosemary Rochford
Journal:  Malar J       Date:  2021-04-21       Impact factor: 2.979

8.  Maternal HIV Infection as a Risk Factor for Primary Epstein-Barr Virus Infection in Kenyan Infants.

Authors:  Gabriela Samayoa-Reyes; Sidney O Ogolla; Ibrahim I Daud; Conner Jackson; Katherine R Sabourin; Arlene Dent; Rosemary Rochford
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

9.  Maternal Vitamin D Status and Adverse Birth Outcomes in Children from Rural Western Kenya.

Authors:  Eunice N Toko; Odada P Sumba; Ibrahim I Daud; Sidney Ogolla; Maxwel Majiwa; Jesse T Krisher; Collins Ouma; Arlene E Dent; Rosemary Rochford; Saurabh Mehta
Journal:  Nutrients       Date:  2016-12-07       Impact factor: 5.717

Review 10.  Parasite Infection, Carcinogenesis and Human Malignancy.

Authors:  Hoang van Tong; Paul J Brindley; Christian G Meyer; Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2016-12-02       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.